Frank Scott, MD
Gastroenterology · Aurora, CONPI 1588822878
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,800 of the $12,002 with a category attached, or 81.7%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 91.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $11,042 and has fallen 98.8% since, to $136 in 2025.
Across 29 payments — averaging $413.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$11K
- AbbVie$577
- Smith+Nephew$130
- Acumed LLC$117
- Bristol Myers Squibb$97
- Pfizer$35
- plus $24 from 1 others
Across 11 payments — averaging $20,986 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$158K
- Takeda Pharmaceuticals U.S.A., Inc.$73K
What the payments were for
- Consulting fees$9,80082%
- Travel & lodging$7837%
- Food & beverage$1,40312%
- Education$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $11,022 |
| AbbVie | 8 | $577 |
| Smith+Nephew | 1 | $130 |
| Acumed LLC | 1 | $117 |
| Bristol Myers Squibb | 1 | $97 |
| Pfizer | 2 | $35 |
| Skeletal Dynamics Inc | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Entyvio$10,534
- Skyrizi$257
- Ascension$130
- EVOS$130
- VLP Mini-MOD$130
- Safeguard$130
- Hat-Trick$130
- ACUMED$117
- InFrame Implant$117
How this compares
$12,002 in reported general payments places this provider in the 85th percentile of 304 gastroenterology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 23 | $1,557 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 44 | $729 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 13 | $304 |
| Omeprazole | 17 | $238 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Aurora
- Mihir WaghAurora$217K
- Steven EdmundowiczAurora$190K
- Raj ShahAurora$98K
- Hazem HammadAurora$57K
- Jennifer ChristieAurora$45K
- Mohammad BilalAurora$36K
- Benjamin ClickAurora$35K
- Sachin WaniAurora$31K
- Mark GerichAurora$9K
- Ariana GreenwoodAurora$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.